Tianjin, China

Shuiping Zhou

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Shuiping Zhou in Pharmaceutical Development

Introduction

Shuiping Zhou is a notable inventor based in Tianjin, China, recognized for his contributions to the field of pharmaceuticals. With a total of 8 patents to his name, he has made significant strides in developing innovative compositions aimed at improving health outcomes.

Latest Patents

Among his latest patents is a pharmaceutical composition designed to protect against myocardial damage and treat heart failure. This composition includes components such as phenolic acids, flavonoids, tanshinones, saponins, and volatile oils, each measured in specific parts by weight. Another significant patent involves the application of substituted cinnamamide derivatives in the preparation of anti-anxiety medications. These derivatives are characterized by a complex structure that allows for the development of effective therapeutic agents.

Career Highlights

Shuiping Zhou is currently associated with Tasly Pharmaceutical Group Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on creating compositions that address critical health issues, showcasing his commitment to advancing medical science.

Collaborations

He collaborates with esteemed colleagues such as Xiaohui Ma and Min Han, further enhancing the research and development efforts within his organization.

Conclusion

Shuiping Zhou's innovative work in pharmaceuticals exemplifies the impact of dedicated inventors in improving healthcare solutions. His patents reflect a deep understanding of medicinal chemistry and a commitment to addressing pressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…